Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO)

Background:  Dengue is a disease of major global importance. While most symptomatic infections are mild, a small proportion of patients progress to severe disease with risk of hypovolaemic shock, organ dysfunction and death.  In the absence of effective antiviral or disease modifying drugs, clinical...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Wellcome Open Res
Main Authors: Nguyen, Nguyet Minh, Chanh, Ho Quang, Tam, Dong Thi Hoai, Vuong, Nguyen Lam, Chau, Nguyen Thi Xuan, Chau, Nguyen Van Vinh, Phong, Nguyen Thanh, Trieu, Huynh Trung, Luong Thi Hue, Tai, Cao Thi, Tam, Dinh The, Trung, Duyen, Huynh Thi Le, Van, Ninh Thi Thanh, Nguyen Than Ha, Quyen, Rivino, Laura, Gallagher, Peter, Jones, Nick K., Geskus, Ronald B., Kestelyn, Evelyne, Yacoub, Sophie
Formato: Artigo
Idioma:Inglês
Publicado em: F1000 Research Limited 2021
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539082/
https://ncbi.nlm.nih.gov/pubmed/33083561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.16053.2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados